EN
Be the global leader of T cell cancer immunotherapy
 
Introduction to TCRCure
Introduction to TCRCure
TCRCure Biopharma Ltd. aims to develop next generation cancer immunotherapies that control tumor progression, convert cancers to manageable chronic diseases, and eventually lead to a cure.
TCRCure Biopharma Ltd. aims to develop next generation cancer immunotherapies that control tumor progression, convert life-threatening cancers to manageable diseases, and eventually lead to cures. We are a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.
 
TCRCure has established two GMP-level manufacturing facilities in Los Angeles and Guangzhou, as well as two research and development, translational medicine centers in North Carolina and Chongqing.
 
As of 2019, TCRCure has over 90 employees, with more than 40% of them being  Ph.Ds. The company has several pipelines of TCR-T cell therapy products for solid tumors including cervical cancer, nasopharyngeal carcinoma,head and neck cancer,lung squamous carcinoma, colorectal cancer, ovarian cancer, multiple myeloma, and brain cancer. TCRCure has started clinical trials and translational medicine research in coordination with the top hospitals in Chongqing, Chengdu, and Guangzhou, China.
 

In addition, TCRCure has solid clinical data and robust pipelines for viral vector and T cell manufacturing. The company has obtained technology authorization, commissioned R&D contracts, received  production orders from pharmaceutical factories, and has attracted millions of USD in funding from top investment companies.

Introduction to TCRCure
LA GMP Center
LA GMP Center
LA R&D Center
LA R&D Center
Durham R&D Center
Durham R&D Center
Durham R&D Center
Durham R&D Center
Guangzhou GMP Center
Guangzhou GMP Center
Guangzhou GMP Center
Guangzhou GMP Center
Chongqing R&D Center
Chongqing R&D Center
Chongqing R&D Center
Chongqing R&D Center

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
Introduction to TCRCure
Immune Cell Therapy
Product and Services
News
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer